KOSDAQ · Healthcare · ₩221B
₩7,070+0.14%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.4% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“제품군과 해외 진출이 성장을 넓히지만 이익은 천천히 따라와요.”
In the company's words · 2026 2분기 filing